Stockscreener 앱 받기
0.8591
4.27%
-0.0383
시간 외 거래:
.86
0.0009
+0.10%
전일 마감가:
$0.8974
열려 있는:
$0.8974
하루 거래량:
62,169
Relative Volume:
0.33
시가총액:
$38.46M
수익:
$80.28M
순이익/손실:
$-38.83M
주가수익비율:
-1.0328
EPS:
-0.8318
순현금흐름:
$-28.67M
1주 성능:
-8.81%
1개월 성능:
-5.07%
6개월 성능:
-25.30%
1년 성능:
-42.73%
1일 변동 폭
$0.8402
$0.90
1주일 범위
$0.774
$0.94
52주 변동 폭
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.8591 | 35.81M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
TELA Bio Inc. (TELA) Slides 5.7% as Shares Approach Critical Support at $0.82Volatility Breakout Picks - newsline.com
TELA Bio (TELA) grants director new RSUs and stock options - Stock Titan
Director Guido J. Neels files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
TELA Bio (NASDAQ: TELA) grants director new stock and options - Stock Titan
Joseph H. Capper joins TELA Bio (TELA) board and files initial insider report - Stock Titan
TELA Bio (TELA) director awarded 11,675 shares and options for 17,335 - Stock Titan
TELA Bio : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership - Stock Titan
TELA Bio (TELA) director Paul Thomas receives RSU and option grants - Stock Titan
Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Shareholders Expand Equity Incentive Plan Authorization - TipRanks
TELA Bio (NASDAQ: TELA) OKs 3.5M-share incentive plan boost - Stock Titan
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesRevenue Recognition Risk - newsline.com
EW Healthcare Partners Fund 2-UGP Secures Board Seat at TELA Bio with 17.23% Stake - TradingView
EW Healthcare funds report 7.7M TELA Bio (TELA) shares and board seat - Stock Titan
TELA Bio Inc Annual Shareholders Meeting Transcript - GuruFocus
TELA Q1 2026 Earnings: EPS Miss Sends Stock Slightly LowerRevenue Inflection Point - newsline.com
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio | 8-K: Current report - Moomoo
TELA Bio Expands Europe Sales as U.S. Growth Slows - MyChesCo
TELA Bio Inc. (TELA) Edges Lower, Tests Key Support After 2.7% DeclineUser Trade Ideas - Newser
Tela Bio Eyes Second-Half Ramp After Mixed Quarter - TipRanks
TELA Bio (TELA) Q1 2026 Results Miss Estimates — EPS $-0.21 vs $-0.19Retail Earnings Report - Newser
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us | Oil & Gas JournalTELA Bio, Inc.Common stock (Nasdaq:TELA) Stock Quote - FinancialContent
Becton Dickinson stock (US0718131099): Antitrust case survives dismissal - AD HOC NEWS
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
TELA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Becton Hernia Mesh Antitrust Case Survives Dismissal - Law360
TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens - Stock Titan
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M - MSN
Q1 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio revenue up 3% to USD 19.1M in Q1 2026 - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2026 Earnings Call Transcript - Insider Monkey
TELA Bio, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
TELA Bio 1Q 2026: Revenue $19.06M, EPS ($0.21) — 10-Q Summary - TradingView
TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong Eur - GuruFocus
TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript Summary - Moomoo
Is TELA Bio (TELA) a Possible Value Trap After Q1 2026? EPS Not - GuruFocus
TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA - Moomoo
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip By Investing.com - Investing.com South Africa
Tela Bio earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tela Bio Q1 2026 earnings miss sparks stock dip - Investing.com Australia
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):